Metabolomic signatures strengthen association between diet and cancer risk in women
Assessing the effect of diet on cancer risk can be challenging as most approaches rely on self-reported dietary intake from food frequency questionnaires (FFQs).
Comment & Opinion
Saturated fat increases the risk of mortality in non-metastatic prostate cancer
ERS 2026: oral IRAK4 inhibitor AZD6793 enters dose-ranging Phase IIb COPD trial
ERS 2026: Brensocatib cuts NCFB exacerbations in NTM history patients
ERS 2026: Sanofi’s lunsekimig hits Phase IIb goals in asthma, Phase III set to follow
ERS 2026: Phase Ib/IIa results support further evaluation of 9MW1911 in COPD
ERS 2026: tozorakimab’s groundbreaking exacerbation reduction sets a new bar in COPD
A practical framework for choosing e-signatures in global trials
